Bulletin
Investor Alert

AmerisourceBergen Corp.

NYS: ABC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 1, 2020, 6:12 p.m.

ABC
/zigman2/quotes/201066379/composite

$

95.15

Change

0.00 0.00%

Volume

Volume 35,529

Quotes are delayed by 20 min

/zigman2/quotes/201066379/composite

Today's close

$ 95.34

$ 95.15

Change

-0.19 -0.20%

Day low

Day high

$94.84

$95.87

Open

52 week low

52 week high

$72.06

$97.50

Open

Kathleen W. Hyle

Kathleen W. Hyle is Non-Executive Chairman for Bunge Ltd. She is also on the board of AmerisourceBergen Corp., Center Stage Associates, Inc. (Maryland) and Sellinger School of Business & Management and Partner at Wkw LLC.

In her past career she occupied the position of Chief Financial Officer for ANC Rental Corp., Treasurer & Vice President at AutoNation, Inc., Chief Operating Officer & Senior Vice President of Constellation Energy Group, Inc., Chief Operating Officer at Constellation Energy Resources LLC, Chief Financial Officer at Constellation Energy Nuclear Group LLC, Chief Financial Officer for Constellation NewEnergy, Inc., Chief Financial Officer for UniStar Nuclear Energy LLC, Chief Financial Officer for National Car Rental System, Inc. and Treasurer & Vice President of The Black & Decker Corp.

Ms. Hyle received an undergraduate degree from Loyola University Maryland, Inc.

Transactions

Date Shares Transaction Value
03/02/2020 1,360   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2020 2,500   Disposition at $95 per share. 237,500
02/12/2020 2,500   Derivative/Non-derivative trans. at $37.43 per share. 93,575
02/05/2020 5,000   Disposition at $90 per share. 450,000
02/05/2020 5,000   Derivative/Non-derivative trans. at $37.43 per share. 187,150
02/04/2020 5,000   Disposition at $88.26 per share. 441,300
02/04/2020 4,347   Disposition at $88.25 per share. 383,623
02/04/2020 9,347   Derivative/Non-derivative trans. at $31.6 per share. 295,365
03/03/2019 1,417   Derivative/Non-derivative trans. at $0 per share. 0
03/05/2018 1,206   Derivative/Non-derivative trans. at $0 per share. 0
12/19/2016 2,648   Disposition at $78.4 per share. 207,604
12/14/2016 3,351   Disposition at $76.95 per share. 257,860

Officers and Executives

Mr. Steven H. Collis
Chairman, President & Chief Executive Officer
Mr. James Francis Cleary
Chief Financial Officer & Executive Vice President
Mr. Dale B. Danilewitz
Chief Information Officer & Executive VP
Ms. Gina K. Clark
Chief Communications & Administration Officer, EVP
Ms. Leslie E. Donato
Chief Strategy Officer & Executive Vice President
Mr. Rafael Augusto Kosa Teixeira
Senior Vice President-Transformation
Ms. Kathy Habecker Gaddes
Chief Compliance Officer & Executive Officer
Mr. Sun Park
Executive Vice President
Dr. Robert P. Mauch
EVP & Group President-Pharmaceutical Distribution
Ms. Ornella Barra
Non-Independent Director
Mr. Jack F. Quinn
Treasurer & Vice President
Mr. Lazarus Krikorian
Principal Accounting Officer, SVP & Controller
Mr. Bennett S. Murphy
Vice President-Investor Relations
Ms. Silvana Battaglia
Chief Human Resources Officer & Executive VP
Mr. John G. Chou
Executive VP, Chief Legal Officer & Secretary
Mr. Dennis M. Nally
Independent Director
Mr. Henry Wadsworth McGee
Independent Director
Mr. Richard W. Gochnauer
Independent Director
Dr. Jane Ellen Henney
Lead Independent Director
Ms. Kathleen W. Hyle
Independent Director
Mr. Michael J. Long
Independent Director
Mr. Lon R. Greenberg
Independent Director
Mr. D. Mark Durcan
Independent Director
Link to MarketWatch's Slice.